In addition, PRMT1 knockdown led to changes in the STAT signaling pathway in the GC TME, invasive M1-like TAM polarization, an enhanced antitumor immune response, and inhibited tumor progression in GC. The gene discussed is PRMT1; the disease is neoplasm.